Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1987 1
1988 1
1989 2
1990 2
1992 1
1993 1
1994 1
1996 1
1999 1
2007 1
2008 2
2009 2
2010 2
2012 1
2014 1
2016 1
2017 3
2018 1
2019 2
2020 3
2021 6
2022 5
2023 6
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial.
Rovin BH, Barratt J, Heerspink HJL, Alpers CE, Bieler S, Chae DW, Diva UA, Floege J, Gesualdo L, Inrig JK, Kohan DE, Komers R, Kooienga LA, Lafayette R, Maes B, Małecki R, Mercer A, Noronha IL, Oh SW, Peh CA, Praga M, Preciado P, Radhakrishnan J, Rheault MN, Rote WE, Tang SCW, Tesar V, Trachtman H, Trimarchi H, Tumlin JA, Wong MG, Perkovic V; DUPRO steering committee and PROTECT Investigators. Rovin BH, et al. Lancet. 2023 Dec 2;402(10417):2077-2090. doi: 10.1016/S0140-6736(23)02302-4. Epub 2023 Nov 3. Lancet. 2023. PMID: 37931634 Clinical Trial.
Efficacy and safety clinical trial with efavirenz in patients diagnosed with adult Niemann-pick type C with cognitive impairment.
Gascón-Bayarri J, Simon PC, Llop R, Carnaval T, Ledesma MD, Rico I, Sánchez-Castañeda C, Campdelacreu-Fumadó J, Calvo-Malvar N, Cos M, de Lama E, Cortés-Romera M, Rodríguez-Bel L, Pérez-Sousa C, Cerdán Sánchez M, Muelas N, Sevillano MD, Mir P, López de Munain A, Ferrer A, Videla S. Gascón-Bayarri J, et al. Among authors: rico i. Medicine (Baltimore). 2022 Dec 2;101(48):e31471. doi: 10.1097/MD.0000000000031471. Medicine (Baltimore). 2022. PMID: 36482560 Free PMC article.
Cognitive decline in adult-onset temporal lobe epilepsy: Insights from aetiology.
Hernández G, Sala-Padró J, Adell V, Rico I, Gasa-Roqué A, Morandeira F, Campdelacreu J, Gascon J, Falip M. Hernández G, et al. Among authors: rico i. Clin Neurol Neurosurg. 2024 Feb;237:108159. doi: 10.1016/j.clineuro.2024.108159. Epub 2024 Feb 8. Clin Neurol Neurosurg. 2024. PMID: 38354426
Premenstrual asthma and atopy markers.
Pereira-Vega A, Sánchez JL, Maldonado JA, Borrero F, Rico IV, Vázquez R, Alvarez F, Ignacio JM, Romero P, Gil FL. Pereira-Vega A, et al. Among authors: rico iv. Ann Allergy Asthma Immunol. 2010 Sep;105(3):218-22. doi: 10.1016/j.anai.2010.06.022. Ann Allergy Asthma Immunol. 2010. PMID: 20800788
Sleep quality in individuals with post-COVID-19 condition: Relation with emotional, cognitive and functional variables.
Carnes-Vendrell A, Piñol-Ripoll G, Ariza M, Cano N, Segura B, Junque C, Béjar J, Barrue C; Nautilus Project Collaborative Group; Garolera M. Carnes-Vendrell A, et al. Brain Behav Immun Health. 2023 Dec 31;35:100721. doi: 10.1016/j.bbih.2023.100721. eCollection 2024 Feb. Brain Behav Immun Health. 2023. PMID: 38269302 Free PMC article.
Neuropsychological impairment in post-COVID condition individuals with and without cognitive complaints.
Ariza M, Cano N, Segura B, Adan A, Bargalló N, Caldú X, Campabadal A, Jurado MA, Mataró M, Pueyo R, Sala-Llonch R, Barrué C, Bejar J, Cortés CU; NAUTILUS-Project Collaborative Group; Junqué C, Garolera M. Ariza M, et al. Front Aging Neurosci. 2022 Oct 20;14:1029842. doi: 10.3389/fnagi.2022.1029842. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36337708 Free PMC article.
47 results